WW International Inc

WW International Inc(WW)の株式分析

$16.200

-0.178 (-1.10%)終値時点

Loading chart…
High
16.452
Open
16.160
VWAP
15.98
Vol
156.97K
Mkt Cap
95.05M
Low
15.300
Amount
2.51M
EV/EBITDA, TTM
3.10

WW International, Inc. provides science-backed weight loss and weight management programs. The Company provides an accessible, holistic model of care through its doctor-recommended Points Program, clinical interventions including weight-loss medications, and community support. Its weight-loss and weight management programs are focused on nutritional and behavior change science. They are comprised of a range of science-based nutritional, activity, behavioral and lifestyle tools and approaches that can be tailored for individual weight goals and, if needed, support the various needs of people taking GLP-1 medications. Its offerings include Behavior Change Programs, WeightWatchers Clinic, Licensing and Consumer Product Sales. Its subscription businesses include digital business, workshops + digital business, clinical business and WeightWatchers for business offering nutritional and behavior change science. Its WW-branded products include bars, snacks, cookbooks and kitchen tools.

AI analysis of WW International Inc (WW)

hold

WW International Inc is currently priced at $16.20, which is below the analyst price target of $20, indicating potential upside. However, the forward P/E ratio is significantly high at 74.07, suggesting that the stock may be overvalued relative to its earnings potential. Additionally, the company has experienced a substantial year-to-date decline of 48.47%, which raises concerns about its stability. The recent positive earnings surprise of 58.43% and a gross margin of 70.32% in Q2 2026 are encouraging signs, but the overall financial performance remains inconsistent, with net income fluctuations and a negative net margin of -30.90% in Q1 2026. Therefore, while there are some positive indicators, the high valuation and recent performance trends suggest a cautious approach is warranted.

バリュエーション指標

The current forward P/E ratio for WW International Inc (WW) is 74.07, compared to its 5-year average forward P/E of -4.74.

Forward P/E

Fair
5Y Average P/E
-4.74
Current P/E
74.07
割高
150.82
割安
-160.31

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
9.33
Current EV/EBITDA
3.10
割高
17.68
割安
0.97

Forward P/S

Fair
5Y Average P/S
0.46
Current P/S
0.25
割高
0.91
割安
0.00

Whales holding WW

A

Aristeia Capital, LLC

+ HoldingWW

+3.11%

3M Return

イベントタイムライン

2026-08-05 (ET)

19:30:00

Company Adjusts FY26 EBITDA Outlook to $105M-$115M

19:30:00

Weight Watchers Reports Q2 Revenue of $162.39M

2026-07-09 (ET)

08:30:00

Sam's Club and WW Collaborate to Launch Wellness Experience

2026-06-16 (ET)

17:00:00

WW International Expands Partnership with CheqUp for UK Weight Management Support

2026-05-07 (ET)

07:10:00

Company Reaffirms FY26 Adjusted EBITDA Guidance of $105M to $115M

ニュース

WW FAQ — answered by Alphio AI

WW International, Inc. provides science-backed weight loss and weight management programs. The Company provides an accessible, holistic model of care through its doctor-recommended Points Program, clinical interventions including weight-loss medications, and community support. Its weight-loss and weight management programs are focused on nutritional and behavior change science. They are comprised of a range of science-based nutritional, activity, behavioral and lifestyle tools and approaches that can be tailored for individual weight goals and, if needed, support the various needs of people taking GLP-1 medications. Its offerings include Behavior Change Programs, WeightWatchers Clinic, Licensing and Consumer Product Sales. Its subscription businesses include digital business, workshops + digital business, clinical business and WeightWatchers for business offering nutritional and behavior change science. Its WW-branded products include bars, snacks, cookbooks and kitchen tools. It operates in the Consumer Non-Cyclicals sector (SERVICES-PERSONAL SERVICES industry).

WW International Inc is currently priced at $16.20, which is below the analyst price target of $20, indicating potential upside. However, the forward P/E ratio is significantly high at 74.07, suggesting that the stock may be overvalued relative to its earnings potential. Additionally, the company has experienced a substantial year-to-date decline of 48.47%, which raises concerns about its stability. The recent positive earnings surprise of 58.43% and a gross margin of 70.32% in Q2 2026 are encouraging signs, but the overall financial performance remains inconsistent, with net income fluctuations and a negative net margin of -30.90% in Q1 2026. Therefore, while there are some positive indicators, the high valuation and recent performance trends suggest a cautious approach is warranted.

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

無料で始める